Many signaling receptors require covalent modification by ubiquitin for agonist-induced down-regulation via endocytic trafficking to lysosomes, a process that is mediated by a conserved set of endosome-associating proteins also required for vacuolar protein-sorting (VPS) in yeast. The delta opioid receptor (DOR) is a G protein-coupled receptor that can undergo agonist-induced proteolysis via endocytic trafficking to lysosomes but does not require covalent modification by ubiquitin to do so. This raises the question of whether lysosomal down-regulation of this "ubiquitination-independent" GPCR is mediated by a completely distinct biochemical mechanism or if similar VPS machinery is involved. Agonist-induced proteolysis of DOR was significantly inhibited by dominant negative mutant versions of Vps4/ Skd1, an AAA-family ATPase required for a late step in lysosomal sorting of ubiquitinated membrane cargo. Furthermore, overexpression and interfering RNA-mediated knockdown indicated that lysosomal trafficking of opioid receptors is also dependent on Hrs, a VPS protein that mediates an early step in lysosomal sorting of ubiquitinated cargo. However, interfering RNA-mediated knockdown of Tsg101, a VPS protein that is essential for an intermediate step of the conserved lysosomal sorting mechanism, did not detectably affect agonistinduced proteolysis of DOR in the same cells in which (ubiquitination-dependent) lysosomal trafficking of epidermal growth factor receptors was clearly inhibited. These results indicate that opioid receptors, despite their ability to undergo efficient agonist-induced trafficking to lysosomes in the absence of covalent modification by ubiquitin, utilize some (Vps4 and Hrs) but perhaps not all (Tsg101) of the VPS machinery required for lysosomal sorting of ubiquitinated membrane cargo.
phosphorylation by G protein-coupled receptor kinases and recruitment of non-visual (␤-) arrestins (1) (2) (3) . Endocytosis can lead to diverse functional consequences depending on the subsequent sorting of endocytosed receptors between divergent downstream membrane pathways. For example, trafficking of endocytosed receptors via a rapid recycling pathway returns them to the plasma membrane in a functionally active state, promoting recovery (or resensitization) of cellular signal transduction (4 -6) . Alternatively, trafficking of endocytosed receptors to lysosomes leads to proteolytic down-regulation of receptors and a prolonged attenuation of cell signaling. It is clear that GPCRs can be "sorted" selectively between these divergent membrane pathways (7) , but, despite considerable recent progress (8 -11) , the biochemical machinery mediating lysosomal sorting of GPCRs in mammalian cells remains poorly defined.
Genetic and biochemical studies in yeast have led to a molecular model of GPCR trafficking to the vacuole, a proteolytic compartment similar to the mammalian lysosome (12) (13) (14) (15) . A key event in this mechanism is the modification of membrane proteins with ubiquitin, a highly conserved 76-residue protein that is attached to the ⑀-amino group of cytoplasmic lysine residues via enzyme-catalyzed isopeptide bond formation (16) . Modification of the yeast GPCR Ste2p with a single ubiquitin chain is sufficient to promote endocytic trafficking to the vacuole (12) , distinguishing this role of mono-ubiquitination in vacuolar targeting from that of polyubiquitination, which targets various soluble and membrane proteins to the proteasome (17) . A large number of genes have been identified that are required for trafficking of ubiquitinated membrane proteins to the vacuole (18, 19) . Two of the protein products of Class E vacuolar protein-sorting (VPS) genes, Vps27p and Vps23p, are thought to function in sequence in the vacuolar sorting mechanism and bind directly to ubiquitinated membrane cargo via ubiquitin-interacting domains. These critical VPS proteins are organized into large multiprotein complexes that are recruited to the endosome membrane in a sequential manner and promote vacuolar sorting by a multistep mechanism requiring the Vps4p AAA family ATPase at a late step, probably to disassociate the endosome-associated protein complexes and thus allow subsequent rounds of sorting to occur. This has led to a model for ubiquitinated protein sorting in diverse organisms mediated by a series of multiprotein "ESCRT" complexes (20 -25) .
Mammalian homologues of most of the yeast VPS genes have been identified, and extensive studies of ligand-induced down-regulation of the epidermal growth factor (EGF) receptor tyrosine kinase have established this receptor as a model for VPS protein function in mammalian cells. Down-regulation of EGF receptors is mediated by ligand-induced endocytosis followed by receptor sorting to lysosomes (26) . Sorting of internalized EGF receptors to lysosomes requires ubiquitination of the receptor (by the E3 ubiquitin ligase Cbl (27) ) as well as several mammalian VPS proteins: hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs, homologue of Vps27p) (28 -31) , tumor susceptibility gene 101 (Tsg101, homologue of Vps23p) (29, 32) , and Vps4/Skd1 (homologue of Vps4p) (33) . As for Vps27p in yeast, Hrs associates with endosome membranes through an interaction with phosphoinositides and is thought to function at an early stage in the sorting mechanism by binding directly to ubiquitinated cargo (34) . Hrs is then thought to recruit additional sorting proteins to the endosome membrane by directly binding to Tsg101 (35, 36) , a homologue of Vps23p that is assembled into a large multiprotein complex (37) and can also bind ubiquitinated cargo (29) . As in yeast, mammalian Vps4 is critical for lysosomal trafficking of receptors and is thought to function at a later stage in the sorting mechanism that does not involve direct binding to ubiquitinated cargo. Hence Hrs, Tsg101, and Vps4 are thought to function sequentially on the endosome membrane to mediate a multistep mechanism by which ubiquitinated EGF receptors are sorted to lysosomes (38, 39) .
Ubiquitination-dependent trafficking of GPCRs to the yeast vacuole requires the same VPS proteins involved in vacuolar sorting of other ubiquitinated membrane cargo (22, 40) . Certain mammalian GPCRs also require covalent modification by ubiquitin for endocytic trafficking to lysosomes (9, 10 ). An interesting observation from recent studies is that not all mammalian GPCRs require ubiquitination to traffic to lysosomes. A lysine-mutant version of the delta opioid receptor, which is unable to be covalently modified by ubiquitin, was observed to undergo efficient ligand-induced trafficking to lysosomes in HEK293 cells (41) . These results, together with evidence that non-covalent interactions of mammalian GPCRs with distinct non-VPS proteins can modulate their lysosomal trafficking (8, 11) , raise fundamental questions about the mechanism by which non-ubiquitinated GPCRs traffic to lysosomes. Namely, is the biochemical machinery mediating ''ubiquitination-independent'' lysosomal trafficking of GPCRs in mammalian cells completely distinct from the VPS protein-mediated mechanism, or is shared VPS machinery involved? If shared machinery is involved, are there any differences in the requirement of specific VPS proteins that might distinguish ubiquitinationindependent lysosomal sorting of opioid receptors from ubiquitination-dependent sorting of EGF receptors?
We have addressed these questions by investigating the role of Hrs, Tsg101, and Vps4 in lysosomal trafficking of DOR in stably transfected HeLa cells, a cell line in which these mammalian VPS proteins are well established to be required for ubiquitination-dependent lysosomal sorting of EGF receptors (28 -30, 33, 36) . Our studies confirm in this cell type, as shown previously in HEK293 cells (41) , that agonist-induced proteolysis of DOR via endocytic trafficking to lysosomes can occur efficiently in the absence of receptor ubiquitination. Nevertheless, this process is strongly dependent on Vps4 and Hrs, but is apparently independent of the core ESCRT protein Tsg101. To our knowledge, the present results are the first to demonstrate a role of mammalian Class E VPS homologue in the lysosomal trafficking of a non-ubiquitinated GPCR, and they suggest an unexpected distinction between the biochemical requirements for lysosomal trafficking of ubiquitination-dependent and -independent membrane cargo.
EXPERIMENTAL PROCEDURES
Cell Culture, cDNA Constructs, and Transfection-The myc-tagged Hrs construct and anti-Hrs antibody were a gift from Harald Stenmark (Norwegian Radium Hospital, Norway), and the Vps4-GFP, Vps4 E228Q-GFP, and Vps4 K173Q-GFP constructs were a gift from Wes Sundquist (University of Utah School of Medicine). HeLa cells were grown in Dulbecco's modified Eagles medium supplemented with 10% fetal bovine serum (University of California, San Francisco, Cell Culture Facility). FLAG-tagged versions of the cloned murine DOR and the cytoplasmic-lysine deleted DOR (DOR-0cK) were generated as previously described (41) , and the cDNAs for both DOR and DOR-0cK were subcloned into pIRESneo3 (Clontech) for generation of stable cell lines. Stably transfected cells expressing epitope-tagged receptors were generated by selection for neomycin resistance using 750 g/ml G418. Neomycin-resistant colonies were isolated and selected based on receptor expression levels (assessed by fluorescence microscopy and Western blot of cell lysate using the M1 anti-FLAG antibody (Sigma)). Saturation analysis by radioligand binding studies using [ 3 H]diprenorphine (Amersham Biosciences) revealed the receptor expression level corresponds to 5-10 pmol of receptor/mg of membrane protein for the DOR and 1-5 pmol/mg for the DOR-0cK.
For transient expression of myc-Hrs or Vps4 constructs, cells were transfected using FuGENE (Roche Applied Science) according to the manufacturer's instructions. Cells expressing FLAG-tagged receptors were harvested by trypsinization and plated in 12-well plates at 80% confluency, before transfection with plasmid DNA. Cells were cultured for a further 48 h before experimentation. Knockdown of Tsg101 and Hrs using RNA oligonucleotides (42) was achieved by transfection of duplex RNA oligonucleotides (Qiagen) corresponding to part of the coding region of human Tsg101 or human Hrs as previously described (28, 43) with LipofectAMINE 2000 (Invitrogen). Cells were plated in 12-well plates at 90% confluency before transfection with duplex RNA strands and carrier plasmid DNA (pcDNA3.0, Invitrogen). Control cells were transfected with nonsense duplex RNA oligonucleotides (AAT-TCTCCGAACGTGTCACG, Qiagen). 24 h later a second identical transfection was carried out, and the cells were left for a further 24 h before experimentation.
Western Blotting for Total Receptor Levels-Immunoblotting of total receptor levels was as previously described (41) . Briefly, cells were transfected as described, and stimulated before washing three times in ice-cold phosphate-buffered saline (PBS) and lysed in extraction buffer (0.1% Triton X-100, 150 mM NaCl, 25 mM KCl, 25 mM Tris, pH 7.4, 1 mM CaCl 2 , 1 g/ml leupeptin, 1 g/ml pepstatin, 1 g/ml aprotinin, 0.5 mM phenylmethylsulfonyl fluoride). Extracts were clarified by centrifugation (12,000 ϫ g for 10 min) and then mixed with SDS sample buffer for denaturation. The proteins were resolved by SDS-PAGE, transferred to nitrocellulose membranes, and probed for FLAG-tagged receptor (M1 antibody, Sigma), EGF receptor (sc-03, Santa Cruz Biotechnology), Tsg101 (sc-7964, Santa Cruz Biotechnology), or Hrs by immunoblotting using horseradish peroxidase-conjugated sheep anti-mouse IgG or donkey anti-rabbit IgG (Amersham Biosciences), and SuperSignal detection reagent (Pierce). Band intensities of unsaturated immunoblots were analyzed and quantified by densitometry using FluorChem 2.0 software (AlphaInnotech Corp.). The amount of FLAG-DOR remaining at each time point was first expressed as a percentage of the amount of FLAG-DOR in the identically transfected unstimulated cells. Data were also expressed as a ratio of transfected cells over control transfected cells for each time point. Assuming there is no difference in receptor levels between the control cells and transfected cells, the ratio would be 1. If the rate of degradation is unaffected by expression of mutants or siRNA transfection, the ratio after 4-h agonist treatment will be unchanged from that in unstimulated cells. Data were pooled across experiments, and statistical analysis was performed by Student's t test. A previously described cell surface biotinylation assay was used to establish FLAG-tagged receptors present at the cell surface (41) . Briefly, stably transfected HeLa cells were grown on 60-mm dishes, washed with ice-cold PBS, and incubated with 300 g/ml sulfo-Nhydroxysuccinimide-biotin (Pierce) in PBS for 30 min at 4°C to biotinylate surface proteins. Following washing with Tris-buffered saline to quench unreacted biotin, cells were returned to 37°C for incubation in media, with or without agonist, before extraction as described above. Biotinylated proteins were isolated from cell extract by immobilization on streptavidin-conjugated Sepharose beads (Amersham Biosciences). Washed beads were eluted with SDS sample buffer before resolving by SDS-PAGE as above.
Fluorescence Microscopy-Colocalization of receptors with lysosomes was visualized using an antibody feeding method. Briefly, cells were plated onto glass coverslips, and surface receptors were labeled by the addition of anti-FLAG antibody to the media. Cells were then incubated for 60 min in the presence of agonist at 37°C, before fixing with 4% formaldehyde in PBS, and processed for immunocytochemical staining as previously described (41) . Lysosomes were localized using lysosomeassociated membrane protein 1 (LAMP1) monoclonal antibody obtained from the Developmental Studies Hybridoma Data Bank. To examine colocalization with Hrs, surface receptors were again labeled by the addition of anti-FLAG antibody to the media. Cells were then incubated for 15 min in the presence of agonist at 37°C, and cells were permeabilized with 0.05% saponin prior to fixation with 4% formaldehyde in PBS. Hrs was detected using anti-Hrs antibody (supplied by Harald Stenmark (31)). Confocal fluorescence microscopy was performed using a Zeiss LSM 510 microscope fitted with a Zeiss 63ϫ numerical aperture 1.4 objective operated in single photon mode with standard filter sets and standard (1 Airy disc) pinhole.
RESULTS

Ubiquitination of DOR Is Not Required for Endocytic Trafficking to Lysosomes in HeLa Cells-
We have previously shown that, unlike several other signaling receptors in various cell types (9, 10, 12, 22, 27, 29, 32) , DOR does not require covalent modification with ubiquitin to traffic to lysosomes after agonist-induced endocytosis in HEK293 cells (41) . This raised the question of whether ubiquitination-independent lysosomal trafficking of this GPCR is a peculiarity of a single cell type or may be a more general property of receptor trafficking in mammalian cells. To address this we examined the endocytic trafficking of epitope-tagged DOR expressed in HeLa cells, another human cell line in which ubiquitination-dependent lysosomal trafficking of other signaling receptors is well established (28 -30, 33, 36) . FLAG-tagged DOR, expressed at moderate levels in stably transfected HeLa cells (see ''Experimental Procedures''), was detected in cell lysates by immunoblotting using anti-FLAG monoclonal antibody. The FLAG-DOR resolved as a heterogeneous protein band, with a prominent immunoreactive protein species resolving between 50 and 60 kDa, consistent with the mature DOR glycoprotein (Fig. 1A ) (44 -46) . This immunoreactive band was not detected in untransfected HeLa cells (not shown), confirming that it represents the expressed FLAG-DOR protein. The amount of immunoreactive FLAG-DOR detected in cell lysates was greatly diminished within several hours after addition of opioid agonist (10 M DADLE) to the culture medium (Fig. 1A ). This prominent band (indicated by the bracket in Fig. 1A ) was analyzed by densitometry, and quantification of the results of multiple experiments indicated that FLAG-DOR exhibited agonist-induced proteolysis with a t1 ⁄2 of ϳ2 h (Fig. 1B) . This is closely comparable to the proteolysis rate observed in HEK293 cells (8, 41, 46) , where agonistinduced proteolysis of DOR occurring in this relatively rapid time course is mediated primarily by receptor trafficking to lysosomes. Identical results were obtained using a surface biotinylation procedure (described under ''Experimental Procedures''), in which the major form of DOR labeled in the plasma membrane had the same electrophoretic mobility as the major species analyzed in the Western blots, was specifically detected in receptor-transfected cells, and was extensively proteolyzed within 4 h of agonist addition (Fig. 1C) . To determine if this process of agonist-induced proteolysis requires ubiquitination of the receptor protein, we utilized a previously described mutant receptor (DOR-0cK (41)) in which all cytoplasmic lysine residues that are potential sites of ubiquitination have been replaced by arginine. FLAG-DOR-0cK exhibited agonist-induced proteolysis in stably transfected HeLa cells (Fig. 1D ) and did so with a similar rate as observed for the wild type DOR (Fig. 1 , compare E with B). Surface biotinylation confirmed that the major form of DOR-0cK labeled in the plasma membrane had the same electrophoretic mobility as the receptor species analyzed in the Western blots and confirmed that surface-labeled DOR-0cK, like DOR, undergoes extensive agonistinduced proteolysis (Fig. 1F) .
FIG. 1. Agonist-induced proteolysis of DOR and DOR-0cK in HeLa cells. A,
HeLa cells stably expressing FLAGtagged DOR were cultured in 12-well plates and stimulated at 37°C with 10 M DADLE for the indicated time period, before extraction and detection by immunoblotting. Shown is a representative anti-FLAG Western blot; the bracket denotes the area of blot analyzed by densitometry. B, quantification of receptor immunoreactivity at various times after agonist addition (determined by densitometry of blots exposed in the linear range), expressed as a percentage of immunoreactive receptors detected in untreated cells. Data were pooled from three independent experiments. C, FLAG-DOR present in the plasma membrane was specifically labeled using surface biotinylation, and surfacelabeled receptors were detected by streptavidin pull-down followed by anti-FLAG immunoblotting. A representative anti-FLAG immunoblot is shown. ''control'' indicates nonspecific signal FLAG detected by streptavidin pull-down of lysates prepared from biotinylated untransfected HeLa cells. ''DOR'' indicates biotinylated receptor immunoreactivity detected from FLAG-DOR-expressing cells that were surfacebiotinylated but not exposed to agonist. ''ϩ4 h DADLE'' indicates biotinylated receptor immunoreactivity detected from FLAG-DOR-expressing cells that were surface-biotinylated and then exposed to 10 M DADLE for 4 h prior to cell lysis. D-F, the corresponding experiments performed using stably transfected HeLa cells expressing FLAG-tagged DOR-0cK.
In HEK293 cells, agonist induced proteolysis of both DOR and DOR-0cK occurring over this time course is mediated primarily by receptor trafficking to lysosomes (8, 41, 46) . We sought to determine if this is also true in HeLa cells. Classic inhibitors of lysosomal proteolysis (leupeptin, chloroquine, and ammonium chloride) strongly inhibited agonist-induced proteolysis of DOR ( Fig. 2A) . This was evident by examining the major species of FLAG-DOR detected in Western blots (indicated by the bracket) as well as a less prominent higher species corresponding to dimeric receptor (indicated by the asterisk). Furthermore, internalized FLAG-DOR was observed in numerous vesicles that colocalized with the late endosome/lysosome marker LAMP1 within 60 min of agonist addition, as resolved by confocal fluorescence microscopy (Fig. 2B) . Agonist-induced proteolysis of DOR-0cK was also strongly inhibited by lysosomal inhibitors (Fig. 2C) , and FLAG-DOR-0cK was detected in numerous LAMP1-positive vesicles within 60 min after endocytosis (Fig. 2D ). Together these observations support the hypothesis that both DOR and DOR-0cK undergo agonist-induced endocytic trafficking to lysosomes in HeLa cells. Furthermore, DADLE-induced proteolysis of DOR observed over this time course, as shown previously in HEK293 cells (8, 41, 46) , appears to be a reliable measure of lysosomal trafficking of receptors in HeLa cells.
Agonist-induced Proteolysis of DOR Is Dependent on Vps4
Activity-The ability of DOR to traffic to lysosomes in the absence of receptor ubiquitination raised the question of whether this GPCR is sorted into this membrane pathway by a completely distinct mechanism than ubiquitination-dependent membrane cargo, or if some components of the sorting mechanism are shared. To begin to address this question, we investigated the potential role of Vps4, an AAA family ATPase that is highly conserved across species and is essential for lysosomal sorting of ubiquitinated membrane cargo in both yeast and mammalian cells (20, 21, 24, 47, 48) . Vps4 is thought to function at a late step in the lysosomal sorting mechanism, after recognition of ubiquitinated membrane proteins by ''upstream'' endosome-associated proteins, and is itself not known to contain ubiquitin-binding domains (24, 47, 49) . Two mutant versions of Vps4, an ATP binding-deficient mutant (K173Q) and an ATP hydrolysis-deficient mutant (E228Q), have been established previously to function as dominant negative alleles when overexpressed in mammalian cells (47) . Stably transfected HeLa cells expressing FLAG-DOR were transiently transfected with plasmids encoding GFP (control) or GFP-tagged versions of wild type Vps4, Vps4 E228Q, or Vps4 K173Q, and effects on FLAG-DOR detected in cell lysates were investigated by immunoblotting (Fig. 3A) . Overexpression of either dominant negative allele of Vps4 resulted in a pronounced increase on FLAG-DOR levels relative to those observed in control (GFP) cells or in cells expressing wild type Vps4 (WT) following agonist treatment, consistent with reduced receptor proteolysis. In some experiments, we noted increased FLAG-DOR levels in Vps4 mutant transfected cells that had not been exposed to opioid agonist (compare lanes 1 and 2 with 3 and 4 from the left) . This was most pronounced in experiments in which relatively high levels of mutant Vps4 expression were achieved, as estimated by intensity of GFP fluorescence (not shown). In all experiments (including those in which no significant increase in steady-state FLAG-DOR was observed), overexpression of both dominant negative Vps4 mutants caused a pronounced increased in receptor levels detected following agonist exposure of cells (lanes 5-12) , suggesting that expression of mutant Vps4 inhibits agonist-induced proteolysis of DOR. This inhibitory effect of dominant negative Vps4 on agonist-induced proteolysis of receptors was confirmed by quantifying receptor immunoreactivity, determined by densitometric scanning of blots exposed in the linear range, and normalizing receptor levels detected from lysate of agonist-treated cells to steady-state levels detected in cells expressing the same constructs that were not exposed to agonist (Fig. 3B) . To further distinguish possible effects of mutant Vps4 on steady-state receptor levels and agonist-induced proteolysis, receptor levels detected in lysate from Vps4-transfected cells was normalized relative to that from control (GFP-transfected) cells under the same treatment condition (see ''Experimental Procedures''). This method, in addition to providing separate estimates of Vps4 effects on steady-state receptor level and agonist-induced proteolysis, facilitated quantitative evaluation of the reproducibility of results across multiple experiments. Using this analysis, mutant Vps4 was confirmed to cause a significant and highly reproducible inhibition of agonist-induced proteolysis of DOR, which greatly exceeded any effect of mutant Vps4 on steady-state levels of FLAG-DOR (Fig. 3C) . As a positive control for effects on ubiquitination-dependent lysosomal sorting, we confirmed that both mutant alleles of Vps4 inhibited agonist-induced proteolysis of EGF receptors to a similar extent as DOR in the same cell clones used for studies of DOR proteolysis (Fig. 3D ). Together these results strongly suggest that the agonist-induced proteolysis of DOR, like that of the EGF receptor, is dependent on Vps4 activity. Thus lysosomal trafficking of DOR is likely to utilize at least some of the same biochemical machinery involved in trafficking of ubiquitination-dependent membrane cargo.
Agonist-induced Proteolysis of DOR Is Also Dependent on Hrs-To further investigate the similarity between the mechanisms mediating lysosomal trafficking of DOR relative to ubiquitination-dependent membrane cargo, we next examined the potential role of Hrs in agonist-induced proteolysis of DOR. Hrs, like Vps4, is a mammalian VPS protein required for lysosomal sorting of ubiquitinated membrane cargo. However, unlike Vps4, which is proposed to function at a late stage in the sorting mechanism, Hrs appears to function at an early stage in this mechanism and can bind directly to ubiquitinated membrane cargo (29, 34) . Hrs contains multiple domains and exists on the endosome membrane in a multiprotein complex (29, 30,  35, 36) , raising the question of whether Hrs might also be involved in lysosomal sorting of DOR. As a first step toward
FIG. 3. Mutant Vps4 inhibits agonist-induced proteolysis of DOR.
A, stably transfected HeLa cells expressing FLAG-tagged DOR were transiently transfected with a control (GFP) plasmid or GFP-tagged versions of Vps4 (WT) or one of the two mutant Vps4 constructs (E228Q or K173Q) before treatment for indicated time with 10 M DADLE, extraction, and receptor immunoblotting. Shown is a representative anti-FLAG Western blot from six independent experiments. Some of the bands are overexposed in the image shown to allow visualization of receptor immunoreactivity in all lanes. B, quantification of receptor immunoreactivity detected in the experiment shown in panel A was determined by scanning densitometry of the bracketed region (corresponding to the same major receptor species as shown in Figs. 1 and 2 ) and performed in the linear range of non-saturated exposures. Bars represent the fraction of FLAG-DOR detected after agonist exposure of cells for 4 h, expressed as a percentage of the amount detected in lysate of cells transfected with the same plasmid but not exposed to agonist. C, quantification of the pooled effects of the indicated Vps4 constructs on proteolysis of FLAG-DOR from cells not exposed to agonist (''0,'' representing steady-state receptor levels) and from cells exposed to 10 M DADLE for four hours (''4 h,'' to assay effects on agonist-induced proteolysis of receptors). Bars represent mean Ϯ S.E. of pooled data (n ϭ 6). *, significant difference from own unstimulated ratio as determined by Student's t test (p Ͻ 0.05). D, effect of mutant Vps4 constructs on amounts of the endogenously expressed EGF receptor in lysates prepared from the same cells, either at steady state (0Ј) or after exposure of cells for 30 or 60 min to 100 ng/ml EGF as described under ''Experimental Procedures.'' Shown is a representative anti-EGF receptor Western blot from three independent experiments. addressing this question we examined the localization of endogenous Hrs protein relative to FLAG-DOR in stably transfected HeLa cells using confocal microscopy. In untreated cells, DOR was localized to the plasma membrane, whereas Hrs was restricted to intracellular structures (not shown). Following agonist treatment, many endosomes containing internalized FLAG-DOR colocalized extensively with Hrs (Fig. 4A) .
To investigate whether Hrs plays a functional role in DOR trafficking, we next examined whether the effect of overexpressing a Myc-tagged version of Hrs on FLAG-DOR proteolysis in HeLa cells. Overexpression of this construct has been shown previously to function as a dominant inhibitor of Hrsmediated lysosomal sorting of EGF receptors (29, 50) . Under these conditions, a pronounced effect on FLAG-DOR levels was observed (Fig. 4B) . In some experiments Myc-Hrs overexpression produced a significant increase in FLAG-DOR levels detected in untreated cells, consistent with the hypothesis that Hrs, like mutant Vps4, can affect steady-state receptor levels when highly overexpressed. However, even in experiments in which little or no increase in steady-state receptor levels was observed, overexpression of Hrs inhibited agonist-induced proteolysis of FLAG-DOR (Fig. 4B) . This observation was verified by normalizing FLAG-DOR detected in lysate from agonisttreated cells relative to that from untreated cells expressing the same constructs (Fig. 4C) . Analysis of FLAG-DOR levels across multiple experiments confirmed that Hrs overexpression produced a significant and reproducible inhibition primarily of agonist-induced proteolysis of FLAG-DOR (Fig. 4D) . Hrs also inhibited agonist-induced proteolysis of endogenously expressed EGF receptors in these cells (Fig. 4E) , as established Data are expressed as FLAG-DOR immunoreactivity detected in lysates prepared at the indicated time after agonist addition, expressed as a percentage of that detected in lysates prepared from cells transfected with the same construct but not exposed to agonist. D, mean Ϯ S.E. (n ϭ 6) of pooled data representing effect of Myc-Hrs overexpression on FLAG-DOR levels in cells not exposed to agonist (''0'') and cells exposed to 10 M DADLE for 4 h (''4'') to detect effects on agonist-induced proteolysis. *, significant difference from unstimulated ratio as determined by Student's t test (p Ͻ 0.05). E, effect of Hrs overexpression on levels of the endogenously expressed EGF receptor in lysates prepared from the same cells, either at steady state (0Ј) or after exposure of cells for 30 or 60 min to 100 ng/ml EGF as described under ''Experimental Procedures.'' Shown is a representative anti-EGF receptor Western blot from three independent experiments. previously in HeLa cells, confirming the dominant negative effect observed and suggesting a potential functional role of Hrs in lysosomal trafficking of DOR.
Another means to manipulate Hrs function in vivo is to ''knock down'' protein expression levels using RNA interference. Knockdown of endogenous Hrs expression by transfection of small interfering RNA (siRNA) has been shown recently to inhibit lysosomal sorting of EGF receptors in HeLa cells (28) . This approach consistently yielded a substantial (ϳ70%) knockdown of endogenous Hrs protein levels in FLAG-DORexpressing HeLa cells (Fig. 5A) . In some experiments Hrs knockdown produced a detectable increase in FLAG-DOR levels at steady state in untreated cells. However the predominant effect of Hrs knockdown, which was observed in all experiments, was to inhibit agonist-induced proteolysis of FLAG-DOR (Fig. 5B) . Normalization of FLAG-DOR from agonisttreated cells relative to untreated cells confirmed this observation (Fig. 5C ). This result was further confirmed across multiple experiments by normalizing receptor detected in siRNA-transfected cells relative to that in control-transfected cells (Fig. 5D) . Knockdown of Hrs also inhibited agonist-induced proteolysis of EGF receptors in the same cells (Fig. 4E) , confirming previous studies demonstrating a critical role of Hrs in lysosomal sorting of EGF receptors. These results strongly suggest that Hrs, in addition to its well established role in sorting ubiquitination-dependent membrane cargo such as the EGF receptor, also functions in lysosomal trafficking of DOR.
We next determined if Hrs is involved in the agonist-induced lysosomal proteolysis of the DOR-0cK mutant receptor (Fig. 6) . Knockdown of Hrs significantly inhibited agonist-induced proteolysis of FLAG-DOR-0cK, as evident both by visual inspection (Fig. 6A) and quantification of Western blots (Fig. 6B) . Normalization of receptor detected from siRNA-transfected relative to control-transfected cells across multiple experiments confirmed that Hrs knockdown significantly inhibits DOR-0cK degradation (Fig. 6C) .
Knock-down of Tsg101 Does Not Inhibit Agonist-induced Proteolysis of DOR-
The observation that agonist-induced proteolysis of DOR is dependent on both Hrs and Vps4, which function at early and late stages in lysosomal sorting of ubiquitinated membrane cargo, respectively, raised the question of whether DOR is sorted to lysosomes by an essentially identical mechanism established for EGF receptors. Hrs is proposed to deliver ubiquitinated membrane proteins to a multiprotein ''ESCRT'' sorting complex associated with the endosome membrane (38, 51) . Tsg101 is a core component of this complex and can bind both ubiquitinated cargo and Hrs (29, 36) . Interfering RNA-mediated knockdown of Tsg101 is a highly specific means for inhibiting ESCRT protein function (43) and has been shown to significantly inhibit lysosomal sorting of EGF receptors (29) . Thus we used this approach to investigate whether Tsg101 is also required for lysosomal trafficking of DOR. Cellular Tsg101 was depleted using an siRNA sequence established previously to function in both HEK293 and HeLa cells (29, 43) , and highly efficient knockdown of the endogenous Tsg101 protein in FLAG-DOR-expressing HeLa cells was confirmed by immunoblotting (Fig. 7A) . Surprisingly, in contrast to manipulations of other VPS proteins that strongly affected DOR proteolysis, we were unable to observe any detectable effect of Tsg101 knockdown on agonist-induced proteolysis of DOR (Fig. 7B) . This was confirmed by normalizing receptor levels relative to those in untreated cells (Fig. 7C) , as well as by normalizing receptor (n ϭ 5) of pooled data representing effect of Hrs knockdown on FLAG-DOR levels in cells not exposed to agonist (''0'') and cells exposed to 10 M DADLE for 4 h (''4'') to detect effects on agonist-induced proteolysis. *, significant difference from unstimulated ratio as determined by Student's t test (p Ͻ 0.05). E, effect of Hrs knockdown on levels of the endogenously expressed EGF receptor in lysates prepared from the same cells, either at steady state (0Ј) or after exposure of cells for 20, 40, or 60 min to 100 ng/ml EGF. Shown is a representative anti-EGF receptor Western blot from three independent experiments. levels from siRNA-transfected relative to control transfected cells across multiple experiments (Fig. 7D) . Nevertheless, in these same cells, Tsg101 knockdown consistently inhibited agonist-induced proteolysis of EGF receptors (Fig. 7E) . In some experiments Tsg101 knockdown produced a significant increase in FLAG-DOR levels in cells not exposed to agonist (Fig.  7F , compare 0Ј time point in panels i and ii). However, even in these experiments we were unable to detect any effect on agonist-induced proteolysis of FLAG-DOR when receptor detected from agonist-treated cells was normalized to that from the corresponding cells not exposed to agonist (Fig. 7G, panels i and ii show quantification of normalized receptor levels from the representative blots shown in Fig. 7F ). We confirmed that Tsg101 knockdown also did not affect agonist-induced proteolysis of the DOR-0cK mutant receptor in HeLa cells (not shown), and identical results (no inhibition of agonist-induced proteolysis of either DOR or DOR-0cK) were obtained following Tsg101 knockdown in HEK293 cells (not shown). Thus, although there are considerable similarities evident in the mechanism by which DOR and EGF receptors traffic to lysosomes (dependence on Vps4 and Hrs), agonist-induced proteolysis of DOR is either insensitive to, or significantly less sensitive to, knockdown of Tsg101 expression.
DISCUSSION
The present results establish that DOR does not require covalent modification with ubiquitin to undergo agonist-induced proteolysis in HeLa cells and indicate that endocytic trafficking of receptors to lysosomes plays a major role in this process. This observation is consistent with a previous study of DOR trafficking in HEK293 cells but stands in marked contrast to lysosomal trafficking of many other membrane proteins, including certain GPCRs and the EGF receptor tyrosine kinase, which require ubiquitination of cytoplasmic lysine residues for lysosomal trafficking in these cells (9, 10, 27) . Taken together with previous evidence for non-covalent protein interactions modulating lysosomal sorting of DOR and certain other mammalian GPCRs (8, 11) , this observation raises the question of whether the mechanism mediating ubiquitination-independent lysosomal trafficking of DOR is at all similar to that mediating trafficking of ubiquitinated membrane cargo. The present study addresses this question using HeLa cells, a cell type in which ubiquitination-dependent lysosomal trafficking mediated by VPS proteins is well established. We have observed that lysosomal trafficking of DOR shares some fundamental biochemical features with the mechanism mediating lysosomal sorting of ubiquitinated membrane proteins. First, our results indicate that Vps4, an AAA family ATPase essential for a late step in lysosomal sorting of the various ubiquitinated membrane proteins, including the EGF receptor tyrosine kinase, is also required for lysosomal trafficking of DOR. Second, we observed that Hrs, a VPS protein that mediates an early step in the ubiquitinationdependent lysosomal sorting mechanism, is also important for lysosomal trafficking of DOR. Yeast homologues of these proteins are well known to be required for sorting of ubiquitinated Ste2p to the vacuole (lysosome equivalent) (22, 40) and are also required for ubiquitination-dependent sorting of the EGF receptor tyrosine kinase in mammalian cells (28, 30, 31, 33) . To our knowledge, the present study is the first to investigate the function of these important sorting proteins in membrane trafficking of a non-ubiquitinated GPCR.
A role of Vps4 in lysosomal trafficking of DOR is perhaps not unexpected, because Vps4 is proposed to function at a late step in the lysosomal sorting mechanism, after recognition of ubiquitinated membrane cargo by Hrs and Tsg101 (24) . Indeed Vps4 is required for vacuolar trafficking of Sna3p, an integral membrane protein that traffics to the vacuole in the absence of ubiquitin modification (52) . It is remarkable that lysosomal trafficking of both DOR and DOR-0cK is dependent on Hrs, because Hrs contains ubiquitin-interacting motifs that are thought to bind directly to ubiquitinated membrane cargo (29, 34) . One possibility is that DOR may interact with Hrs via a distinct (non-ubiquitinated) protein domain, or link to Hrs via an additional cytoplasmic protein. The latter hypothesis is consistent with previous studies demonstrating a role of additional protein interactions in post-endocytic sorting of certain GPCRs and with biochemical studies indicating that cytoplas- FIG. 6 . siRNA-mediated knockdown of Hrs inhibits agonistinduced proteolysis of DOR-0cK. Stably transfected HeLa cells expressing FLAG-tagged DOR-0cK were transfected with control (Ϫ) or Hrs (ϩ) duplex siRNA as described under ''Experimental Procedures,'' before treatment for indicated time with 10 M DADLE, extraction, and immunoblotting. A single exposure is shown in which receptor immunoreactivity can be observed in all lanes. A, effect of Hrs knockdown on FLAG-DOR-0cK detected after the indicated times of agonist exposure. Shown is a representative anti-FLAG Western blot from five independent experiments. B, quantification of the blot shown in panel A, determined by scanning densitometry of the bracketed region in non-saturated exposures. Data are expressed as FLAG-DOR detected in lysate prepared at the indicated time after agonist addition, expressed as a percentage of that detected in lysate from cells transfected with the same RNA duplex but not exposed to agonist. C, mean Ϯ S.E. (n ϭ 5) of pooled data representing effect of Hrs knockdown on FLAG-DOR levels in cells not exposed to agonist (''0'') and cells exposed to 10 M DADLE for 3 h (''3'') to detect effects on agonist-induced proteolysis. *, significant difference from unstimulated ratio as determined by Student's t test (p Ͻ 0.05).
mic Hrs is assembled into a large multiprotein complex (8, 28, 30, 53, 54) .
Hrs binds directly to Tsg101, and this interaction is proposed to function both in recruiting the core ESCRT complex to the endosome membrane and in ''handing off '' membrane cargo from Hrs in a sequential lysosomal sorting mechanism (35, 36) . It is therefore surprising that lysosomal trafficking of DOR (and DOR-0cK), while strongly dependent on Hrs, was not detectably affected by knockdown of Tsg101. This is particularly remarkable, because we used the same RNA interference methodology and obtained a comparably strong knockdown of Tsg101 expression, as has been previously shown to be sufficient to substantially inhibit Tsg101-mediated functions in HeLa cells (29, 43) . Moreover, we confirmed that agonist-induced proteolysis of EGF receptors was inhibited by Tsg101 siRNA in the same cells while having no detectable effect on agonist-induced proteolysis of either the wild type DOR (Fig. 7) or a mutant receptor that contains no cytoplasmic lysine residues (not shown). Together these results indicate that, although ubiquitination-independent lysosomal sorting of DOR utilizes some of the same machinery (Vps4 and Hrs) that is required for lysosomal sorting of ubiquitinated membrane cargo, lysosomal sorting of DOR is remarkably insensitive to knockdown of Tsg101 expression.
It is important to note that RNA interference greatly reduced, but did not completely ablate, Tsg101 expression in siRNA-transfected cells. Thus we do not have a true genetic null and cannot presently exclude some role of Tsg101 in lysosomal trafficking of DOR. Indeed, in Tsg101-depleted cells we were sometimes able to observe an increase in steady-state levels of both DOR (Fig. 7F) and DOR-0cK (not shown). However, even on these occasions, no effect was observed on agonist-induced proteolysis of receptors when receptor amounts detected in agonist-treated cells were normalized to amounts in Data are expressed as FLAG-DOR detected in lysates prepared at the indicated time after agonist addition, expressed as a percentage of that detected from cells transfected with the same RNA duplex but not exposed to agonist. D, mean Ϯ S.E. (n ϭ 6) of pooled data indicating a lack of detectable effect of Hrs knockdown on FLAG-DOR levels in cells not exposed to agonist (''0'') and in cells exposed to 10 M DADLE for 4 h (''4''). E, effect of Tsg101 knockdown on levels of the endogenously expressed EGF receptor from the same cells, either at steady state (0Ј) or after exposure of cells for 20, 40, or 60 min to 100 ng/ml EGF. Shown is a representative anti-EGF receptor Western blot from three independent experiments. F, examples of anti-FLAG Western blots showing no increase (i) or a detectable increase (ii) in steady-state FLAG-DOR levels (''0'' indicates cells not exposed to agonist) and the amount of FLAG-DOR detected in lysate from the same experiments after exposure of cells to 10 M DADLE for 4 h (''4 h'') . G, quantification of the results shown in panel F, determined by scanning densitometry of the bracketed region shown in panel F in non-saturated exposures, in which FLAG-DOR detected in lysate from cells after exposure to 10 M DADLE for 4 h was normalized as a percentage of that detected in lysate from the corresponding cells not exposed to agonist. ''control'' denotes agonist-induced proteolysis of FLAG-DOR in control siRNA-transfected cells. ''siRNA'' indicates agonist-induced proteolysis of FLAG-DOR in cells transfected with Tsg101 siRNA. ''i'' and ''ii'' correspond to the examples of independent experiments shown in panel F.
control (untreated) cells. Therefore an intriguing alternative possibility is that lysosomal sorting of DOR is truly independent of Tsg101. This would be surprising based on our current understanding of the mechanism mediating lysosomal sorting of ubiquitinated membrane cargo, in which Tsg101 is an obligate intermediate between Hrs and Vps 4 and is a core component of the central ESCRT I subcomplex (24, 38, 51) . In this regard it is interesting to note that budding of certain enveloped viruses from mammalian cells, which utilizes similar VPS machinery as lysosomal sorting (37, 43) , can occur in a Vps4-dependent but Tsg101-independent manner involving an alternative protein linkage with VPS proteins functioning ''downstream'' of Tsg101 (55) .
Further study will be required to elucidate the function of specific VPS proteins in mediating endocytic sorting of mammalian GPCRs, to determine how non-ubiquitinated receptors interact with the VPS machinery and to further investigate the possibility that certain GPCRs may bypass specific VPS proteins that are essential for sorting of ubiquitinated membrane cargo. The present results make a significant step forward by establishing a role of VPS proteins in lysosomal trafficking of a mammalian GPCR, even in the absence of receptor ubiquitination, and suggesting the existence of an unexpected distinction between the biochemical requirements for lysosomal sorting of distinct ubiquitination-dependent and -independent membrane cargo.
